Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 0 | 186 | 0 | 0 | 0.00 | 93.00 | ||
52 | Current Pharmacogenomics and Personalized Medicine | journal | 0.291 Q3 | 20 | 30 | 85 | 2789 | 112 | 75 | 1.61 | 92.97 | |
53 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 23 | 64 | 2121 | 117 | 64 | 1.86 | 92.22 | ||
54 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.961 Q2 | 43 | 28 | 85 | 2577 | 251 | 84 | 1.96 | 92.04 | |
55 | Current Pharmaceutical Biotechnology | journal | 1.160 Q1 | 97 | 231 | 252 | 21146 | 909 | 230 | 3.16 | 91.54 | |
56 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.126 Q4 | 17 | 33 | 93 | 3010 | 24 | 85 | 0.22 | 91.21 | |
57 | Drug Design, Development and Therapy | journal | 0.640 Q1 | 94 | 38 | 84 | 3421 | 232 | 82 | 3.11 | 90.03 | |
58 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.341 Q1 | 108 | 114 | 262 | 10207 | 950 | 234 | 3.16 | 89.54 | |
59 | Therapeutic Advances in Neurological Disorders | journal | 0.457 Q3 | 68 | 27 | 84 | 2375 | 149 | 76 | 1.98 | 87.96 | |
60 | Current Drug Therapy | journal | 0.197 Q2 | 20 | 33 | 84 | 2889 | 58 | 81 | 0.59 | 87.55 | |
61 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.140 Q4 | 28 | 25 | 75 | 2156 | 23 | 75 | 0.28 | 86.24 | |
62 | Current Computer-Aided Drug Design | journal | 0.531 Q2 | 32 | 32 | 74 | 2728 | 163 | 70 | 1.91 | 85.25 | |
63 | Current Topics in Pharmacology | journal | 0.120 Q4 | 8 | 13 | 42 | 1102 | 9 | 42 | 0.23 | 84.77 | |
64 | Pharmaceuticals | journal | 0.431 Q2 | 87 | 89 | 208 | 7520 | 256 | 204 | 1.23 | 84.49 | |
65 | Expert Opinion on Biological Therapy | journal | 1.312 Q1 | 102 | 141 | 459 | 11869 | 1848 | 452 | 4.34 | 84.18 | |
66 | Expert Opinion on Therapeutic Patents | journal | 1.129 Q1 | 88 | 112 | 329 | 9333 | 991 | 320 | 3.86 | 83.33 | |
67 | CNS Neuroscience and Therapeutics | journal | 1.437 Q1 | 91 | 83 | 118 | 6890 | 558 | 110 | 4.46 | 83.01 | |
68 | Inflammation and Allergy - Drug Targets | journal | 0.972 Q2 | 55 | 59 | 129 | 4860 | 480 | 124 | 3.89 | 82.37 | |
69 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 47 | 4 | 0 | 327 | 0 | 0 | 0.00 | 81.75 | ||
70 | Reviews on Recent Clinical Trials | journal | 0.718 Q2 | 35 | 30 | 75 | 2410 | 171 | 74 | 2.31 | 80.33 | |
71 | Current Enzyme Inhibition | journal | 0.183 Q4 | 19 | 25 | 63 | 2002 | 28 | 61 | 0.49 | 80.08 | |
72 | Journal of Receptor, Ligand and Channel Research | journal | 0.659 Q2 | 13 | 5 | 5 | 394 | 14 | 5 | 2.80 | 78.80 | |
73 | Trends in Pharmacological Sciences | journal | 5.422 Q1 | 244 | 90 | 249 | 6986 | 2845 | 232 | 11.29 | 77.62 | |
74 | Expert Opinion on Investigational Drugs | journal | 1.541 Q1 | 117 | 142 | 487 | 11009 | 2256 | 471 | 4.88 | 77.53 | |
75 | Current Neuropharmacology | journal | 1.309 Q1 | 103 | 94 | 102 | 7032 | 445 | 97 | 3.51 | 74.81 | |
76 | Pharmacognosy Reviews (discontinued) | journal | 0.355 Q3 | 68 | 23 | 70 | 1716 | 105 | 70 | 1.50 | 74.61 | |
77 | Expert Review of Clinical Pharmacology | journal | 0.297 Q2 | 60 | 69 | 197 | 5043 | 143 | 167 | 0.77 | 73.09 | |
78 | Expert Opinion on Pharmacotherapy | journal | 0.800 Q2 | 93 | 259 | 847 | 18824 | 2415 | 814 | 2.99 | 72.68 | |
79 | Expert Review of Vaccines | journal | 1.405 Q1 | 105 | 167 | 435 | 11738 | 1689 | 350 | 3.91 | 70.29 | |
80 | Current Drug Discovery Technologies | journal | 0.740 Q2 | 49 | 38 | 95 | 2659 | 277 | 90 | 3.02 | 69.97 | |
81 | Neuropsychopharmacology | journal | 4.150 Q1 | 249 | 254 | 807 | 17601 | 6542 | 771 | 7.85 | 69.30 | |
82 | Milestones in Drug Therapy | book series | 0.104 Q4 | 6 | 18 | 41 | 1246 | 2 | 41 | 0.05 | 69.22 | |
83 | Cardiovascular Therapeutics | journal | 0.700 Q2 | 54 | 57 | 128 | 3887 | 288 | 115 | 2.19 | 68.19 | |
84 | Toxins | journal | 0.337 Q3 | 116 | 91 | 168 | 6200 | 187 | 167 | 1.11 | 68.13 | |
85 | Nano Today | journal | 6.990 Q1 | 175 | 65 | 132 | 4358 | 1527 | 102 | 11.19 | 67.05 | |
86 | Journal of Toxicology | journal | 0.153 Q4 | 47 | 47 | 9 | 3138 | 6 | 9 | 0.67 | 66.77 | |
87 | Frontiers in Pharmacology | journal | 0.166 Q3 | 154 | 88 | 41 | 5841 | 32 | 41 | 0.78 | 66.38 | |
88 | Current Radiopharmaceuticals | journal | 0.226 Q3 | 32 | 40 | 55 | 2644 | 35 | 50 | 0.64 | 66.10 | |
89 | Neuromethods | book series | 0.185 Q2 | 24 | 300 | 140 | 19806 | 63 | 127 | 0.45 | 66.02 | |
90 | Open Vaccine Journal | journal | 0.270 Q2 | 10 | 4 | 37 | 262 | 16 | 36 | 0.43 | 65.50 | |
91 | Pharmaceutics | journal | 0.274 Q2 | 106 | 49 | 30 | 3202 | 24 | 29 | 0.80 | 65.35 | |
92 | Clinical Medicine Insights: Therapeutics | journal | 0.113 Q4 | 11 | 44 | 39 | 2873 | 9 | 39 | 0.23 | 65.30 | |
93 | Neurotoxicity Research | journal | 1.439 Q1 | 84 | 97 | 202 | 6297 | 742 | 198 | 3.70 | 64.92 | |
94 | British Journal of Pharmacology | journal | 1.868 Q1 | 244 | 462 | 1634 | 29783 | 7685 | 1545 | 3.99 | 64.47 | |
95 | Current Drug Delivery | journal | 0.599 Q1 | 72 | 68 | 160 | 4369 | 347 | 159 | 1.92 | 64.25 | |
96 | Drug Development Research | journal | 0.366 Q3 | 67 | 83 | 168 | 5296 | 194 | 161 | 1.29 | 63.81 | |
97 | Neuropharmacology | journal | 2.293 Q1 | 191 | 323 | 771 | 20594 | 3973 | 758 | 5.18 | 63.76 | |
98 | Molecular Diagnosis and Therapy | journal | 0.759 Q2 | 68 | 32 | 115 | 2040 | 280 | 108 | 1.96 | 63.75 | |
99 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 38 | 84 | 2420 | 194 | 83 | 2.33 | 63.68 | ||
100 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.337 Q1 | 150 | 292 | 936 | 18526 | 2928 | 701 | 2.78 | 63.45 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®